Recombinant Antibody Network’s first industry partnership will enable development of potential novel therapeutics.
Program helps researchers develop skills, learn about technology commercialization.
Trailblazing publication based on UChicagoTech startup uses digital technology to enhance grade school math education.
New compounds developed by professor Dmitri Talapin and his research group.
Start working with UChicagoTech. Report your new invention, research reagent, software application, or other idea: